en/health – 34. oldal

• Weight Loss Isn’t a Level Playing Field: Choosing Between GLP-1s, Surgery, and Sustainable Habits
  2026-01-13

  Weight loss outcomes vary widely because biology, environment, and access to care are not equal. Here’s how to think clearly about GLP-1 medications, bariatric surgery, and the everyday habits that make results last.

• Weight-loss shots: real risks, rebound effects, and safer long-term alternatives
  2026-01-13

  Weight-loss injections can be effective, but they also come with medical risks, legal quality concerns, and a common rebound problem after stopping. Here’s how to think about safety, sustainability, and better long-term strategies.

• Weight-loss injections in 2026: what the latest MariTide data suggests—and why rebound and safety still matter
  2026-01-13

  New reports suggest Amgen’s MariTide may help some people maintain weight loss for up to two years. Here’s what that could mean in practice, why weight regain after stopping is common, and how to approach safety and treatment choices.

• Weight-Loss Drugs in 2026: Cheaper GLP-1s, New GLP-3s, and What It Means for Your Health
  2026-01-13

  Weight-loss medications are changing fast: prices are dropping in some markets, new drug classes like GLP-3 are emerging, and pill versions are expanding options. Here’s what to know about benefits, limits, safety, and smart next steps.

• GLP-1s, New GLP-3s, and the Future of Weight-Loss Medicine: What to Know Before You Jump In
  2026-01-13

  GLP-1 weight-loss drugs are becoming mainstream, new multi-hormone options are emerging, and prices are shifting globally. Here’s a clear, practical guide to what’s changing, what it means for patients, and what to ask your clinician.

• What Happens When You Stop Weight-Loss Medications—and How to Lose Weight Safely Without Getting Scammed
  2026-01-12

  Weight-loss drugs can deliver meaningful results, but stopping them often changes appetite and weight trajectories. Learn what to expect, how to reduce regain risk, and how to spot common weight-loss scams.

• Celebrity Weight Loss Headlines: What the Stories Miss—and What Actually Matters for Health
  2026-01-12

  Recent celebrity weight-loss stories spark curiosity, but they can also blur the line between appearance, health, and medical treatment. Here’s a grounded guide to interpreting these headlines and focusing on sustainable wellness.

• What Happens When You Stop GLP-1 Weight-Loss Drugs (Wegovy, Mounjaro): Why Weight Often Returns—and How to Maintain Results
  2026-01-12

  GLP-1 and GIP/GLP-1 injections can deliver major weight loss, but many people regain weight after stopping. Here’s why it happens, what changes in the body, and practical strategies to protect your progress.

• Weight-loss drugs in 2026: costs, access, and how to eat safely while using GLP-1 medications
  2026-01-12

  GLP-1 weight-loss medications can change appetite, grocery spending, and health outcomes—but the real “value” depends on safety, nutrition, cost, and long-term plans. Here’s a practical guide to access, expectations, and food rules that help reduce side effects.

• Weight-Loss Medications in 2026: Access, Costs, and Healthy Eating While on GLP‑1 Drugs
  2026-01-12

  GLP‑1 weight-loss drugs are expanding through clinics, pharmacies, and discount platforms—raising new questions about eligibility, affordability, and nutrition. Here’s a practical, health-first guide to access, costs, and smart food rules while using these medications.